Selecta Biosciences Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters2023-10-31

* Selecta Biosciences Inc is expected to show a fall in quarterly revenue when it reports results

* The Watertown Massachusetts-based company is expected to report

a 46.8% decrease in revenue to $11.025 million from $20.71 million a year ago, according to the mean estimate from 6 analysts, based on Refinitiv data.

* Refinitiv's mean analyst estimate for Selecta Biosciences Inc is for a loss of 6 cents per share.

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months.

* Wall Street's median 12-month price target for Selecta Biosciences Inc is $4, above its last closing price of $1.23.

Previous quarterly performance (using preferred earnings measure in US dollars).

QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT IBES MET, SE %

E® ESTIMATE MISSED

Jun. 30 2023 -0.08 -0.08 -0.07 Beat 12.5

Mar. 31 2023 -0.09 -0.09 -0.14 Missed -60.7

Dec. 31 2022 -0.08 -0.07 0.04 Beat 154.9

Sep. 30 2022 0.03 -0.01 -0.05 Missed -775.7

Jun. -0.06 -0.08 0.06 Beat 177.8

30 2022

Mar. 31 2022 -0.10 -0.11 0.23 Beat 312.3

Dec. 31 2021 -0.08 -0.07 0.03 Beat 141.2

Sep. 30 2021 -0.03 -0.07 -0.16 Missed -115.4

This summary was machine generated October 30 at 18:33 GMT. All figures in US dollars unless otherwise stated.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2379532527?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-10-31 02:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2379532527","market":"us","top_or_hot":-1,"title":"Selecta Biosciences Inc expected to post a loss of 6 cents a share - Earnings Preview","media":"Reuters","content":"<html><body><p>* <a href=\"https://laohu8.com/S/SELB\">Selecta Biosciences Inc</a>     is expected to show a fall in quarterly revenue when it reports  results </p><p>   * The Watertown Massachusetts-based  company is expected to report</p><p>a 46.8% decrease in revenue to $11.025 million from $20.71 million a year ago, according to the mean estimate from 6 analysts, based on Refinitiv data. </p><p>   * Refinitiv's mean analyst estimate for Selecta Biosciences Inc is for a loss of 6 cents per share. </p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  </p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * Wall Street's median 12-month price target for Selecta Biosciences Inc is $4, above its last closing price of $1.23. </p><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><p>QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI</p><p>ENDING        ARTESTIMAT  IBES                 MET,    SE %</p><p>              E®          ESTIMATE             MISSED  </p><p>Jun. 30 2023  -0.08       -0.08      -0.07     Beat    12.5</p><p>Mar. 31 2023  -0.09       -0.09      -0.14     Missed  -60.7</p><p>Dec. 31 2022  -0.08       -0.07      0.04      Beat    154.9</p><p>Sep. 30 2022  0.03        -0.01      -0.05     Missed  -775.7</p><p>Jun.        -0.06       -0.08      0.06      Beat    177.8</p><p>30 2022                                                </p><p>Mar. 31 2022  -0.10       -0.11      0.23      Beat    312.3</p><p>Dec. 31 2021  -0.08       -0.07      0.03      Beat    141.2</p><p>Sep. 30 2021  -0.03       -0.07      -0.16     Missed  -115.4</p><p>This summary was machine generated October 30 at 18:33 GMT.  All figures in US dollars  unless otherwise stated.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Selecta Biosciences Inc expected to post a loss of 6 cents a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSelecta Biosciences Inc expected to post a loss of 6 cents a share - Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-10-31 02:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* Selecta Biosciences Inc     is expected to show a fall in quarterly revenue when it reports  results    * The Watertown Massachusetts-based  company is expected to reporta 46.8% decrease in revenue ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2379532527","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2379532527","pubTimestamp":1698690798,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* Selecta Biosciences Inc     is expected to show a fall in quarterly revenue when it reports  results    * The Watertown Massachusetts-based  company is expected to reporta 46.8% decrease in revenue ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Selecta Biosciences Inc。预计每股亏损6美分——收益预览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SELB":1},"content_text":"* Selecta Biosciences Inc     is expected to show a fall in quarterly revenue when it reports  results    * The Watertown Massachusetts-based  company is expected to reporta 46.8% decrease in revenue to $11.025 million from $20.71 million a year ago, according to the mean estimate from 6 analysts, based on Refinitiv data.    * Refinitiv's mean analyst estimate for Selecta Biosciences Inc is for a loss of 6 cents per share.    * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"     * The mean earnings estimate of analysts was unchanged in the last three months.    * Wall Street's median 12-month price target for Selecta Biosciences Inc is $4, above its last closing price of $1.23. Previous quarterly performance (using preferred earnings measure in US dollars). QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRIENDING        ARTESTIMAT  IBES                 MET,    SE %              E®          ESTIMATE             MISSED  Jun. 30 2023  -0.08       -0.08      -0.07     Beat    12.5Mar. 31 2023  -0.09       -0.09      -0.14     Missed  -60.7Dec. 31 2022  -0.08       -0.07      0.04      Beat    154.9Sep. 30 2022  0.03        -0.01      -0.05     Missed  -775.7Jun.        -0.06       -0.08      0.06      Beat    177.830 2022                                                Mar. 31 2022  -0.10       -0.11      0.23      Beat    312.3Dec. 31 2021  -0.08       -0.07      0.03      Beat    141.2Sep. 30 2021  -0.03       -0.07      -0.16     Missed  -115.4This summary was machine generated October 30 at 18:33 GMT.  All figures in US dollars  unless otherwise stated.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2379532527"}